FI954131A0 - Heterocyclic compounds and their preparation and use - Google Patents
Heterocyclic compounds and their preparation and useInfo
- Publication number
- FI954131A0 FI954131A0 FI954131A FI954131A FI954131A0 FI 954131 A0 FI954131 A0 FI 954131A0 FI 954131 A FI954131 A FI 954131A FI 954131 A FI954131 A FI 954131A FI 954131 A0 FI954131 A0 FI 954131A0
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- heterocyclic compounds
- compounds
- forebrain
- hippocampus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Abstract
The present invention relates to therapeutically active azacyclic compounds. The novel compounds are useful as stimulants of the cognitive function of the forebrain and hippocampus of mammals and especially in the treatment of Alzheimer's disease, severe painful conditions and glaucoma.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/026,708 US5376668A (en) | 1990-08-21 | 1993-03-05 | Heterocyclic compounds |
PCT/DK1994/000095 WO1994020495A1 (en) | 1993-03-05 | 1994-03-04 | Heterocyclic compounds and their preparation and use |
Publications (2)
Publication Number | Publication Date |
---|---|
FI954131A FI954131A (en) | 1995-09-04 |
FI954131A0 true FI954131A0 (en) | 1995-09-04 |
Family
ID=21833368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI954131A FI954131A0 (en) | 1993-03-05 | 1995-09-04 | Heterocyclic compounds and their preparation and use |
Country Status (12)
Country | Link |
---|---|
US (7) | US5376668A (en) |
EP (1) | EP0687265B1 (en) |
JP (3) | JPH08507298A (en) |
CN (1) | CN1046721C (en) |
AT (1) | ATE212345T1 (en) |
AU (1) | AU695110B2 (en) |
CA (1) | CA2157580A1 (en) |
DE (1) | DE69429717T2 (en) |
FI (1) | FI954131A0 (en) |
NO (1) | NO306677B1 (en) |
NZ (1) | NZ262374A (en) |
WO (1) | WO1994020495A1 (en) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5545638A (en) * | 1993-12-21 | 1996-08-13 | Novo Nordisk A/S | Method of treating gastrointestinal motility disorders |
IL112024A (en) * | 1993-12-21 | 1999-07-14 | Novo Nordisk As | Pharmaceutical compositions comprising tetrahydropyridine derivatives substituted with oxadiazole or thiadiazole for treating gastrointestinal motility disorders |
US5929247A (en) * | 1994-10-24 | 1999-07-27 | Eli Lilly And Company | Heterocyclic compounds and their preparation and use |
US5998404A (en) * | 1994-10-24 | 1999-12-07 | Eli Lilly And Company | Heterocyclic compounds and their use |
US5488056A (en) * | 1994-10-31 | 1996-01-30 | Eli Lilly And Company | Method for treating anxiety |
CA2202776A1 (en) * | 1994-10-31 | 1996-05-09 | Franklin Porter Bymaster | Method for treating anxiety |
US5565475A (en) * | 1994-11-08 | 1996-10-15 | Muhlhauser; Mark A. | Method of treating urinary bladder dysfunctions with 3-tetrahydropyridine derivatives |
US5852037A (en) * | 1995-11-13 | 1998-12-22 | Eli Lilly And Company | Method for treating anxiety |
AU1141497A (en) * | 1995-11-29 | 1997-06-19 | Eli Lilly And Company | Heterocyclic compounds and their use |
US5998434A (en) * | 1995-12-06 | 1999-12-07 | Eli Lilly And Company | Composition for treating pain |
NZ324594A (en) * | 1995-12-07 | 1999-09-29 | Lilly Co Eli | A method and composition for treating pain using a composition comprising an azacyclic azabicyclic or tetrahydropyridine compound and an analgesic |
US6117890A (en) * | 1996-08-01 | 2000-09-12 | Eli Lilly And Company | Method for treating bipolar disorder |
EP0821958A3 (en) * | 1996-08-01 | 1998-07-08 | Eli Lilly And Company | Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline) for treating excessive aggression |
US6090829A (en) * | 1996-08-01 | 2000-07-18 | Eli Lilly And Company | Method for treating excessive aggression |
EP0821957A3 (en) * | 1996-08-01 | 1998-04-22 | Eli Lilly And Company | Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline) for treating substance abuse |
US6043258A (en) * | 1996-08-01 | 2000-03-28 | Eli Lilly And Company | Method for treating disruptive behavior disorders with xanomeline |
PT821955E (en) * | 1996-08-01 | 2002-07-31 | Lilly Co Eli | Use of 3- (4-HEXYLXY-1,2,5-TIADIAZOL-3-YL) -1,2,5,6-TETRAHYDRO-1-METHYLPYRIDINE (XANOMELINE) FOR THE TREATMENT OF BIPOLAR DISEASE |
EP0821959A3 (en) * | 1996-08-01 | 1998-09-16 | Eli Lilly And Company | Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine for treating nicotine withdrawal |
US6034108A (en) * | 1997-07-28 | 2000-03-07 | Eli Lilly And Company | Method for treating mental retardation |
US6554798B1 (en) | 1998-08-18 | 2003-04-29 | Medtronic Minimed, Inc. | External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
US6376675B2 (en) * | 1999-01-22 | 2002-04-23 | The University Of Toledo | Muscarinic receptor agonists |
US6239134B1 (en) | 1999-03-03 | 2001-05-29 | American Home Products Corp. | Diazole derivatives as serotonergic agents |
KR100351629B1 (en) * | 2000-08-29 | 2002-09-11 | 한국화학연구원 | 5-(4-Substituted-[1,2,5]thiadiazol-3-yl)-3-methyl-1,2,3,4-tetrahydropyrimidine derivatives and process for preparing them |
US20030212379A1 (en) * | 2002-02-26 | 2003-11-13 | Bylund Adam David | Systems and methods for remotely controlling medication infusion and analyte monitoring |
US20030212344A1 (en) * | 2002-05-09 | 2003-11-13 | Vadim Yuzhakov | Physiological sample collection devices and methods of using the same |
US7343188B2 (en) * | 2002-05-09 | 2008-03-11 | Lifescan, Inc. | Devices and methods for accessing and analyzing physiological fluid |
US7250443B2 (en) * | 2002-08-23 | 2007-07-31 | Chiron Corporation | Pyrrole based inhibitors of glycogen synthase kinase 3 |
CA2511746C (en) | 2003-11-06 | 2013-03-26 | Lifescan, Inc. | Drug delivery pen with event notification means |
US6923498B1 (en) * | 2003-11-18 | 2005-08-02 | Brent Alan Mecham | Recreational vehicle cover |
DE102005021587A1 (en) * | 2005-05-10 | 2006-11-16 | BSH Bosch und Siemens Hausgeräte GmbH | Refrigeration appliance and operating method for it |
US7678363B2 (en) * | 2005-08-26 | 2010-03-16 | Braincells Inc | Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs |
EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
CN101374836A (en) * | 2005-12-27 | 2009-02-25 | 托莱多大学 | Muscarinic agonists and methods of use thereof |
AU2007292848A1 (en) * | 2006-09-08 | 2008-03-13 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
US20110294835A1 (en) | 2008-05-15 | 2011-12-01 | The Board Of Trustees Of The University Of Illinois | Muscarinic Agonists as Cognitive Enhancers |
US9549928B2 (en) | 2011-04-29 | 2017-01-24 | The University Of Toledo | Muscarinic agonists as enhancers of cognitive flexibility |
WO2021097427A1 (en) * | 2019-11-15 | 2021-05-20 | Karuna Therapeutics, Inc. | Xanomeline derivatives and methods for treating neurological disorders |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ219646A (en) * | 1986-03-27 | 1990-10-26 | Merck Sharp & Dohme | Oxadiazole derivatives of azacyclics for treating cns disorders |
GB8610432D0 (en) * | 1986-04-29 | 1986-06-04 | Akzo Nv | Amino-thiazole & oxazole derivatives |
GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
GB8717446D0 (en) * | 1987-07-23 | 1987-08-26 | Merck Sharp & Dohme | Chemical compounds |
NZ225999A (en) * | 1987-09-10 | 1992-04-28 | Merck Sharp & Dohme | Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions |
IE63906B1 (en) * | 1987-11-13 | 1995-06-14 | Novo Nordisk As | Azabicyclic compounds and their preparation and use |
EP0322182A3 (en) * | 1987-12-22 | 1992-01-02 | Beecham Group Plc | Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
NZ227841A (en) * | 1988-02-12 | 1991-08-27 | Merck Sharp & Dohme | Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions |
DK162892C (en) * | 1988-07-04 | 1992-05-11 | Novo Nordisk As | 1,2,5,6-TETRAHYDROPYRIDINE COMPOUNDS, THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE |
US5043345A (en) * | 1989-02-22 | 1991-08-27 | Novo Nordisk A/S | Piperidine compounds and their preparation and use |
EP0459568A3 (en) * | 1990-05-31 | 1992-09-30 | Merck Sharp & Dohme Ltd. | Substituted oxadiazoles and thiadiazoles for use in the treatment of glaucoma and novel compounds having such use |
DK198390D0 (en) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND USE |
DK198490D0 (en) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND USE |
JPH06503563A (en) * | 1990-11-29 | 1994-04-21 | アラーガン、インコーポレイテッド | Uses of pyridine derivatives in the treatment of ocular hypertension |
-
1993
- 1993-03-05 US US08/026,708 patent/US5376668A/en not_active Ceased
-
1994
- 1994-03-04 EP EP94908992A patent/EP0687265B1/en not_active Expired - Lifetime
- 1994-03-04 DE DE69429717T patent/DE69429717T2/en not_active Expired - Fee Related
- 1994-03-04 AU AU62029/94A patent/AU695110B2/en not_active Ceased
- 1994-03-04 CA CA002157580A patent/CA2157580A1/en not_active Abandoned
- 1994-03-04 NZ NZ262374A patent/NZ262374A/en unknown
- 1994-03-04 WO PCT/DK1994/000095 patent/WO1994020495A1/en active IP Right Grant
- 1994-03-04 CN CN94191893A patent/CN1046721C/en not_active Expired - Fee Related
- 1994-03-04 JP JP6519483A patent/JPH08507298A/en active Pending
- 1994-03-04 AT AT94908992T patent/ATE212345T1/en not_active IP Right Cessation
- 1994-04-04 US US08/513,851 patent/US5773452A/en not_active Expired - Fee Related
- 1994-12-22 US US08/362,031 patent/US5571826A/en not_active Expired - Fee Related
-
1995
- 1995-05-30 US US08/455,300 patent/US5559136A/en not_active Ceased
- 1995-05-30 US US08/453,605 patent/US5658932A/en not_active Expired - Fee Related
- 1995-09-04 NO NO953462A patent/NO306677B1/en not_active IP Right Cessation
- 1995-09-04 FI FI954131A patent/FI954131A0/en unknown
-
1997
- 1997-06-12 US US08/874,054 patent/US5919805A/en not_active Expired - Fee Related
-
1998
- 1998-02-18 US US09/025,266 patent/USRE36375E/en not_active Expired - Fee Related
-
2000
- 2000-04-12 JP JP2000115892A patent/JP3378556B2/en not_active Expired - Fee Related
-
2002
- 2002-02-07 JP JP2002031327A patent/JP2002302489A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU6202994A (en) | 1994-09-26 |
CN1121717A (en) | 1996-05-01 |
DE69429717D1 (en) | 2002-03-14 |
CA2157580A1 (en) | 1994-09-15 |
JP2002302489A (en) | 2002-10-18 |
NO306677B1 (en) | 1999-12-06 |
EP0687265B1 (en) | 2002-01-23 |
US5571826A (en) | 1996-11-05 |
WO1994020495A1 (en) | 1994-09-15 |
NZ262374A (en) | 1997-06-24 |
US5658932A (en) | 1997-08-19 |
US5919805A (en) | 1999-07-06 |
FI954131A (en) | 1995-09-04 |
AU695110B2 (en) | 1998-08-06 |
JP3378556B2 (en) | 2003-02-17 |
DE69429717T2 (en) | 2002-08-14 |
NO953462L (en) | 1995-11-03 |
US5376668A (en) | 1994-12-27 |
ATE212345T1 (en) | 2002-02-15 |
JP2000309587A (en) | 2000-11-07 |
US5773452A (en) | 1998-06-30 |
EP0687265A1 (en) | 1995-12-20 |
US5559136A (en) | 1996-09-24 |
CN1046721C (en) | 1999-11-24 |
USRE36375E (en) | 1999-11-02 |
JPH08507298A (en) | 1996-08-06 |
NO953462D0 (en) | 1995-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI954131A0 (en) | Heterocyclic compounds and their preparation and use | |
KR960701049A (en) | Heterocyclic compounds and their preparation and use | |
FI930745A0 (en) | HETEROCYCLISM FOERENINGAR OCH DERAS FRAMSTAELLNING OCH ANVAENDNING | |
SG68567A1 (en) | Heterocyclic compounds and their preparation and use | |
FI930746A0 (en) | HETEROCYCLISM FOERENINGAR OCH DERAS FRAMSTAELLNING OCH ANVAENDNING |